{"id":266199,"date":"2026-09-24T09:59:17","date_gmt":"2026-09-24T04:29:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=266199"},"modified":"2026-09-24T09:59:17","modified_gmt":"2026-09-24T04:29:17","slug":"why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/","title":{"rendered":"Marksans Pharma Stock Scales New 52-Week Peak at Rs 351: Key Reasons Behind the Surge"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma Ltd. (MARKSANS)<\/a> share price reached a fresh 52-week high of Rs 350.75 today and later stood at Rs 343.9, down 1.02% from the previous close. Market cap was Rs 15,072.23 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 24 September 2026 at 9:48 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Marksans Pharma Share Price was in focus on 24 September 2026 at 9:48 AM IST after the stock touched a fresh 52-week high of Rs 350.75 and later closed at Rs 343.9, down 1.02% from the previous close of Rs 347.45. The company\u2019s market capitalisation stood at Rs 15,072.23 crore. The data confirms a one-year high for Marksans Pharma Ltd. (MARKSANS), while the latest close shows the stock ended below the session peak. Based on the supplied figures, the event is relevant because it places Marksans Pharma Share Price among the day\u2019s notable stock news items in the Indian stock market, but the data does not establish a company-specific reason for the move.<\/p>\n<p>The session opened at Rs 347.25, moved between Rs 341.95 and Rs 350.75, and finished at Rs 343.9. Turnover was Rs 1.94 crore. The fresh 52-week high, together with the company\u2019s market cap and valuation metrics, gives investors a concrete snapshot of Marksans Pharma Share Price Today. Univest is tracking this Marksans Pharma Stock News event as a price-led development supported by verified market data.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Marksans_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Marksans Pharma Share Price Today: Price Action Analysis\">Marksans Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Marksans_Pharma_Ltd_MARKSANS_Fundamental_Analysis\" title=\"Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis\">Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Why_Investors_Are_Watching_Marksans_Pharma\" title=\"Why Investors Are Watching Marksans Pharma\">Why Investors Are Watching Marksans Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#About_Marksans_Pharma\" title=\"About Marksans Pharma\">About Marksans Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Track_Marksans_Pharma_Share_Price_on_Univest\" title=\"Track Marksans Pharma Share Price on Univest\">Track Marksans Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#What_happened_to_Marksans_Pharma_Share_Price_today\" title=\"What happened to Marksans Pharma Share Price today?\">What happened to Marksans Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Did_Marksans_Pharma_set_a_new_52-week_high\" title=\"Did Marksans Pharma set a new 52-week high?\">Did Marksans Pharma set a new 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#What_is_Marksans_Pharma_market_capitalisation\" title=\"What is Marksans Pharma market capitalisation?\">What is Marksans Pharma market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#How_is_Marksans_Pharma_valued_on_earnings_and_book_value\" title=\"How is Marksans Pharma valued on earnings and book value?\">How is Marksans Pharma valued on earnings and book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#How_do_Marksans_Pharma_profitability_ratios_compare_with_the_industry\" title=\"How do Marksans Pharma profitability ratios compare with the industry?\">How do Marksans Pharma profitability ratios compare with the industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-marksans-pharma-ltd-share-price-52-week-high-2026-09-24\/#Which_peers_are_useful_for_Marksans_Pharma_Share_Price_comparison\" title=\"Which peers are useful for Marksans Pharma Share Price comparison?\">Which peers are useful for Marksans Pharma Share Price comparison?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Marksans Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 343.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 347.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -3.55 (-1.02%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 347.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 350.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 341.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.94 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,072.23 crore<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) traded at Rs 343.9 versus the previous close of Rs 347.45, a fall of 1.02%. The stock opened at Rs 347.25, reached a high of Rs 350.75 and touched a low of Rs 341.95.<\/p>\n<p>Marksans Pharma Share Price Today shows a session that first extended to a fresh 52-week high of Rs 350.75 and then settled lower at Rs 343.9. The stock opened at Rs 347.25, compared with the previous close of Rs 347.45, and moved within a range of Rs 341.95 to Rs 350.75. That means the latest close was Rs 3.55 below the previous close and Rs 6.85 below the day\u2019s high. Turnover of Rs 1.94 crore provides the value of shares transacted during the session. In simple terms, Marksans Pharma Share Price has marked a one-year high and then ended below the peak, making the day notable for stock price news rather than for any stated company-specific trigger.<\/p>\n<p>For readers following Marksans Pharma Share Price Live, the session matters because it records a fresh yearly high in the same session even though the closing price was lower than the peak. That makes the day\u2019s price action the central development in Marksans Pharma Stock News.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Ltd_MARKSANS_Fundamental_Analysis\"><\/span><strong>Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,072.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 11.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 70.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) fundamental metrics show P\/E 30.47x, P\/B 4.95x, ROE 15.31%, ROCE 21.1%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Marksans Pharma Ltd. has a market capitalisation of Rs 15072.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 30.47x, P\/B at 4.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.31% and ROCE of 21.1%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 11.4, book value per share of Rs 70.16, dividend yield of 0.26%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.33x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.47x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.48x to 762.66x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.32%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,072.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 745.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Marksans Pharma Ltd. (MARKSANS) has a P\/E ratio of 30.47x, which is below the benchmark median of 32.33x, a difference of -5.75%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Marksans Pharma Ltd. (MARKSANS) has a ROE of 15.31%, which is above the benchmark median of 11.69%, a difference of +30.97%. Marksans Pharma Ltd. (MARKSANS) has a ROCE of 21.1%, which is above the benchmark median of 13.32%, a difference of +58.41%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Natco Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NATCOPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14,596.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Concord Biotech Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CONCORDBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,013.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">59.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,518.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Astrazeneca Pharma India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTRAZEN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,773<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sudeepphrm\/sudeep-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sudeep Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUDEEPPHRM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13,540.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">74.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.5<\/td>\n<\/tr>\n<\/table>\n<p>Marksans Pharma Ltd. (MARKSANS) has a P\/E ratio of 30.47x compared with the displayed peer median of 59.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.31% compares with a peer median of 16.3% across the companies shown in the table. ROCE stood at 21.1% versus the displayed peer median of 18.04%, providing a capital-efficiency comparison. Marksans Pharma Ltd. (MARKSANS) has a market capitalisation of Rs 15,072.23 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Marksans_Pharma\"><\/span><strong>Why Investors Are Watching Marksans Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Marksans Pharma Share Price touched a fresh 52-week high of Rs 350.75 in the session.<\/li>\n<li>The stock later closed at Rs 343.9 after opening at Rs 347.25 and trading between Rs 341.95 and Rs 350.75.<\/li>\n<li>Market capitalisation stood at Rs 15,072.23 crore.<\/li>\n<li>Valuation shows a P\/E of 30.47, P\/B of 4.95, ROE of 15.31% and ROCE of 21.1%.<\/li>\n<li>In the same-industry benchmark, the company\u2019s P\/E is below the median, while ROE and ROCE are above the median.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Marksans_Pharma\"><\/span><strong>About Marksans Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Marksans Pharma Ltd. (MARKSANS) is part of the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data identifies the company by name and market listing context, and its current share price event has placed Marksans Pharma Share Price in the spotlight for stock news readers. The article\u2019s verified figures capture the company through market capitalisation, valuation, earnings and return ratios rather than through broad assumptions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Marksans_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Marksans Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma Ltd. (MARKSANS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Univest tracks Marksans Pharma Share Price, Marksans Pharma Share Price Today, Marksans Pharma Stock News and Marksans Pharma Share News in one place. Readers can monitor live price updates, 52-week levels, valuation ratios, shareholding pattern, financial results and sector comparisons through the Univest stock page.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_happened_to_Marksans_Pharma_Share_Price_today\"><\/span><strong>What happened to Marksans Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma Share Price touched a fresh 52-week high of Rs 350.75 and then closed at Rs 343.9, down 1.02% from the previous close of Rs 347.45. The session also recorded turnover of Rs 1.94 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Marksans_Pharma_set_a_new_52-week_high\"><\/span><strong>Did Marksans Pharma set a new 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Marksans Pharma Share Price reached Rs 350.75, which is the fresh 52-week high in the supplied data. The stock later ended below that peak, but the yearly high remains the key price event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Marksans_Pharma_market_capitalisation\"><\/span><strong>What is Marksans Pharma market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma\u2019s market capitalisation was Rs 15,072.23 crore. That places the company above the same-industry median market cap of Rs 745.38 crore and close to the industry average of Rs 14,295.86 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Marksans_Pharma_valued_on_earnings_and_book_value\"><\/span><strong>How is Marksans Pharma valued on earnings and book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma trades at a P\/E of 30.47 and a P\/B of 4.95. EPS is Rs 11.4 and book value per share is Rs 70.16, which gives a clear earnings and accounting-value reference.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Marksans_Pharma_profitability_ratios_compare_with_the_industry\"><\/span><strong>How do Marksans Pharma profitability ratios compare with the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma reports ROE of 15.31% and ROCE of 21.1%. Both are above the same-industry median and average, which places the company ahead of the benchmark central tendency on these profitability measures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_peers_are_useful_for_Marksans_Pharma_Share_Price_comparison\"><\/span><strong>Which peers are useful for Marksans Pharma Share Price comparison?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied peers include Natco Pharma, Concord Biotech, Alembic Pharmaceuticals, Astrazeneca Pharma India and Sudeep Pharma. They provide a useful comparison set for Marksans Pharma Share Price on P\/E, P\/B, ROE, ROCE and market cap.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marksans Pharma Ltd. Share Price hits a new 52-week high at Rs 343.9. marking a -1.02% rise today. Market cap stands at Rs 15,072.23 crore.<\/p>\n","protected":false},"author":29,"featured_media":266198,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-266199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["266198"],"rank_math_title":["Marksans Pharma Share Price: 52-week high, valuation view"],"rank_math_description":["Marksans Pharma Share Price touched a fresh 52-week high at Rs 350.75. Read the price action, valuation, sector and peer comparison."],"rank_math_focus_keyword":["Marksans Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/marksans-pharma-stock-scales-new-52-week-peak-at-rs-351-key-reasons-behind-the.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=266199"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266199\/revisions"}],"predecessor-version":[{"id":266200,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/266199\/revisions\/266200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/266198"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=266199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=266199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=266199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}